Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide: Chelmsford, Massachusetts Thursday, July 3, 202 ...

CHELMSFORD, Mass. & NOVI, Mich. & DÜSSELDORF, Germany & TOKYO, July 02, 2025--Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan for CIPN.

From morning aches to chilly toes, uncover the common foot problems you may be missing—and find out how to keep your feet ...

Excessive thirst and weight changes are well-known signs of diabetes—but some strange symptoms can be easy to overlook or ...

Plantar fasciitis, bunions, and arthritis are all among the common causes of foot pain. Learn what to do when your feet hurt and when to see a doctor.

Medically reviewed by Jeffrey S. Lander, MD ATTR-CM is a rare medical condition that stands for transthyretin amyloid ...